Novavax Inc. | Key People and Executives
Stanley C. Erck
President, Chief Executive Officer & Director
John O. Marsh
Director-Emeritus
Rajiv Indravadan Modi
Director
Richard H. Douglas
Independent Director
Gary C. Evans
Independent Director
Michael A. McManus
Independent Director
Stanley C. Erck
President, Chief Executive Officer & Director
Timothy Jon Hahn
Senior VP-Global Manufacturing Operations
John J. Trizzino
CFO, Treasurer, Chief Business Officer & Senior VP
Louis F. Fries
Chief Medical Officer & Senior Vice President
Chris Dunne
Vice President-Finance
Gregory M. Glenn
President-Research & Development
Iksung Cho
Vice President-Biostatistics
Jody Lichaa
Vice President-Quality Assurance
Brian Rosen
Vice President-Government Affairs & Policy
Cynthia N. Oliver
Senior VP-Process Development Operations
Mervyn L. Hamer
Vice President-Manufacturing
Russell P. Wilson
Senior Vice President-Business Development
John O. Marsh
Director-Emeritus
Rajiv Indravadan Modi
Director
Erika Trahan
Senior Manager-Investor & Public Relations
Jill Hoyt
Vice President-Human Resources
John A. Herrmann
Secretary, Senior Vice President & General Counsel
Amy B. Fix
Senior Vice President-Regulatory Affairs
Richard H. Douglas
Independent Director
Gary C. Evans
Independent Director
Michael A. McManus
Independent Director
| Address |
20 Firstfield Road
Gaithersburg Maryland 20878
United States
|
|
Employees
|
- |
| Website |
http://www.novavax.com |
| Updated |
09/14/2018 |
| Novavax, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the provision of development of recombinant nanoparticle vaccines and adjuvants. Its product pipeline targets infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus, seasonal influenza, pandemic influenza, and Ebola virus. The company was founded in 1987 and is headquartered in Gaithersburg, MD. |
